6-Hydroxydopamine-induced nuclear factor-kappaB activation in PC12 cells

Biochemical Pharmacology

Volumn 62, Issue 4, 2001, Pages 473-481

  Blum, David ^a,b   Torch, Sakina ^b   Nissou, Marie France ^c   Verna, Jean Marc ^b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b HÔPITAL MICHALLON   (France)

^c Laboratoire d'Immunologie   (France)

Author keywords

6 Hydroxydopamine; Bcl 2; NF kappaB; Parkinson's disease; PC12 cells

Indexed keywords

ACETYLCYSTEINE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXIDOPAMINE; PARTHENOLIDE; PROTEIN; PROTEIN BCL 2; PROTEIN BFL 1; REACTIVE OXYGEN METABOLITE; SYNAPTOTAGMIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CATECHOLAMINERGIC SYSTEM; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; GENE EXPRESSION; NONHUMAN; OXIDATIVE STRESS; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; DRUG INTERACTIONS; NERVE DEGENERATION; NF-KAPPA B; OXIDATIVE STRESS; OXIDOPAMINE; PC12 CELLS; PLANT EXTRACTS; PROTECTIVE AGENTS; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; REACTIVE OXYGEN SPECIES; SESQUITERPENES;

EID: 0035882750     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(01)00680-3     Document Type: Article

References (59)

1. Multiple redox regulation in NF-κB transcription factor activation
2. Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB
3. Control of apoptosis by Rel/NF-kappaB transcription factors
4. NF-κB: A crucial transcription factor for glial and neuronal cell function NF-κB: A crucial transcription factor for glial and neuronal cell function
5. Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation
6. Transcription factor NF-κB is activated in primary amyloid β peptides and in neurones surrounding early plaques from patients with Alzheimer's disease
7. Induction of NF-κB-like transcription factors in brain areas susceptible to kainate toxicity
8. Nuclear factor-kappa B contributes to excitotoxin-induced apoptosis in rat striatum
9. Global cerebral ischemia activates nuclear factor-κB prior to evidence of DNA fragmentation
10. Nuclear factor-kappa B activation in permanent intraluminal focal cerebral ischemia in the rat
11. Janus faces of NF-κB: Neurodestruction versus neuroprotection
12. N-acetyl-serotonin (normelatonin) and melatonin protect neurons against oxydative challenges and suppress the activity of the transcription factor NF-κB
13. ++ accumulation
14. Activation of NF-κB protects hippocampal neurons against oxydative-stress induced apoptosis: Evidence for induction of manganese superoxyde dismutase and suppression of peroxynitrite production and protein tyrosine nitration
15. Inhibition of nuclear factor kappa B (NF-κB) activity induces nerve growth factor-resistant apoptosis in PC12 cells
16. High constitutive NF-κB activity mediates resistance to oxydative stress in neuronal cells
17. The oxydant stress hypothesis in Parkinson's disease: Evidence supporting it
18. Hydrogen peroxide mediates amyloid beta protein toxicity
19. Oxidative stress interference with the nuclear factor-κB activation pathways
20. Activation of NF-κB protects hippocampal neurons against oxydative-stress induced apoptosis: Evidence for induction of manganese superoxyde dismutase and suppression of peroxynitrite production and protein tyrosine nitration
21. Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor kappaB
22. Nuclear translocation of NF-κB is increased in dopaminergic neurons patients with Parkinson's disease
23. The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls
24. Chemical evidence for 6-hydroxydopamine to be an endogeneous toxic factor in the pathogenesis of Parkinson's Disease
25. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: Contribution to the apoptotic theory in Parkinson's disease
26. Regional effects of 6-hydroxydopamine (6-OHDA) on free radical scavengers in the rat brain
27. Free radical-generated neurotoxicity of 6-hydroxydopamine
28. Toxic effects of apomorphine on rat cultured neurons and glial C6 cells, and protection with antioxidants
29. Participation of active oxygen species in 6-hydroxydopamine toxicity to a human neuroblastoma cell line
30. Extracellular toxicity of 6-hydroxydopamine on PC12 cells
31. Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis
32. p53 and Bax activation in 6-OHDA-induced apoptosis in PC12 cells
33. L attenuates 6-hydroxydopamine-induced neuronal apoptosis
34. Temporal and subunit-specific modulations of the Rel/NF-κB transcription factors through CD28 costimulation
35. Autoregulation of IκBα activity
36. Sesquiterpene lactones specifically inhibit activation of NF-kappa B by preventing the degradation of I kappa B-alpha and I kappa B-beta
37. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide
38. Linkage of the BH4 domain of Bcl-2 and the nuclear factor kappaB signaling pathway for suppression of apoptosis
39. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis
40. Antiapoptotic role of NF-κB in the auto-oxidized dopamine-induced apoptosis of PC12 cells
41. Interaction among mitochondria, mitogen-activated protein kinases, and nuclear factor-kappaB in cellular models of Parkinson's disease
42. A family of serine proteases expressed exclusively in myelo-monocytic cells specifically processes the nuclear factor-κB subunit p65 in vitro and may impair human immunodeficiency virus replication in these cells
43. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1
44. The role of hydroxyl radical as a messenger in the activation of nuclear transcription factor NF-kappaB
45. +-induced dopaminergic neuronal cell death: Role of caspases, ROS, and JNK
46. Intrastriatal dopamine injection induces apoptosis through oxidation-involved activation of transcription factors AP-1 and NF-kappaB in rats
47. Redox signaling: Nitrosylation and related target interactions of nitric oxide
48. Inhibition of the expression of inducible cyclooxygenase and proinflammatory cytokines by sesquiterpene lactones in macrophages correlates with the inhibition of MAP kinases
49. Involvement of caspase-like proteinases in apoptosis of neuronal PC12 cells and primary cultured microglia induced by 6-hydroxydopamine
50. Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity
51. Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo
52. Bcl-x short is elevated following severe global ischaemia in rat brains
53. NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes
54. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis
55. NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis
56. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons
57. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control
58. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
59. Inhibition of caspase cascade by HTLV-I tax through induction of NF-kappaB nuclear translocation